Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Joseph O. Jacobson
Harvard University
128Publications
25H-index
2,222Citations
Publications 128
Newest
Published in Journal of Clinical Oncology 28.25
Joseph O. Jacobson25
Estimated H-index: 25
(Harvard University)
Published on Jul 3, 2019in JAMA Oncology 22.42
Lisa S. Rotenstein7
Estimated H-index: 7
(Harvard University),
Yichen Zhang1
Estimated H-index: 1
(Harvard University),
Joseph O. Jacobson25
Estimated H-index: 25
(Harvard University)
Published on Jul 17, 2019in Journal of Oncology Practice
Jessica A. Zerillo5
Estimated H-index: 5
(BIDMC: Beth Israel Deaconess Medical Center),
Kurt W. Lowery (Harvard University)+ 3 AuthorsSusan T. Haas8
Estimated H-index: 8
(Harvard University)
Published on May 20, 2019in Journal of Clinical Oncology 28.25
Prabhsimranjot Singh5
Estimated H-index: 5
(Harvard University),
Amanda Brito (Harvard University)+ 7 AuthorsOsama E. Rahma12
Estimated H-index: 12
(Harvard University)
Trevor J. Royce8
Estimated H-index: 8
(UNC: University of North Carolina at Chapel Hill),
Kathy Dwyer1
Estimated H-index: 1
(Harvard University)
+ 3 AuthorsRoy B. Tishler38
Estimated H-index: 38
(Harvard University)
Purpose Medical errors in radiation oncology (RO) practice have received significant national attention over the last decade. Medical errors can lead to malpractice cases. Better characterizing these events can educate providers with the goal of improving patient care. Methods and Materials The Controlled Risk Insurance Company Strategies’ Comparative Benchmarking System (CBS) represents approximately 30% of all closed US malpractice cases and includes the experience of more than 30 academic hos...
Published on Feb 1, 2019in Health Affairs 5.71
Joseph O. Jacobson25
Estimated H-index: 25
(Harvard University)
How patients view oncologists—and how oncologists view themselves—matters when difficult decisions must be made.
Published on Jan 1, 2019in Journal of Oncology Practice
Chris I. Wong (Harvard University), Jessica A. Zerillo5
Estimated H-index: 5
(BIDMC: Beth Israel Deaconess Medical Center)
+ 3 AuthorsKristen K. McNiff (Harvard University)
PURPOSE:The development of strategies to prevent or mitigate cancer treatment–related adverse events (AEs) is necessary to improve patient experience, safety, and cost containment. To develop a strategy to easily identify and mitigate AEs, we sought to understand the frequency and severity of those that resulted in hospitalizations.METHODS:We retrospectively characterized hospitalizations of ambulatory adult patients with solid tumor cancers within 30 days of chemotherapy administration using me...
Published on Dec 1, 2018in Journal of Oncology Practice
Jessica A. Zerillo5
Estimated H-index: 5
,
Victoria Carballo3
Estimated H-index: 3
+ 3 AuthorsJoseph O. Jacobson25
Estimated H-index: 25
Purpose:Training clinical and supportive staff in quality improvement (QI) theory and use of QI tools has the potential to improve oncology care delivery. We report our combined experience of providing training to oncologists in a variety of local settings and assess the effect of the training on individual participants and for institutions.Methods:Multidisciplinary oncology teams at a comprehensive cancer center, an academic medical center, and community practices were led through experiential ...
Published on Oct 20, 2018in Journal of Clinical Oncology 28.25
Jing Jing Wang Yakowec (Harvard University), Ingrid Stendhal (Harvard University)+ 1 AuthorsJoseph O. Jacobson25
Estimated H-index: 25
(Harvard University)
296Background: Quantifying the performance of a cancer center’s cancer registry is important to plan for resources needed to address shortcomings and projected increases in workload. The objective of this project was to understand the workflow, reporting requirements, and existing documentation of the cancer registry at Dana-Farber Cancer Institute (DFCI) in order to build a dashboard that quantifies monthly performance. Methods: Current state workflow maps were created detailing the three phase...
Published on Oct 20, 2018in Journal of Clinical Oncology 28.25
Sadiqa Mahmood (Harvard University), Eli Schwamm1
Estimated H-index: 1
(Harvard University)
+ 9 AuthorsJoseph O. Jacobson25
Estimated H-index: 25
(Harvard University)
326Background: The immune checkpoint inhibitors (ICIs) confer a risk of unique inflammatory immune-related adverse events (irAEs), which are highly distinct from the adverse events historically observed with cytotoxic therapy. To develop a strategy for easier identification and mitigation of irAEs, we sought to understand the frequency of ED visits and hospitalizations in 90 days following ICI start by implementing a rapid learning system (RLS). Methods: We convened an Immunotherapy Toxicities M...
12345678910